BE2012C011I2 - The use of an 8a-azalide for the manufacture of a medicament for treating or preventing infections in livestock - Google Patents

The use of an 8a-azalide for the manufacture of a medicament for treating or preventing infections in livestock

Info

Publication number
BE2012C011I2
BE2012C011I2 BE2012C011C BE2012C011C BE2012C011I2 BE 2012C011 I2 BE2012C011 I2 BE 2012C011I2 BE 2012C011 C BE2012C011 C BE 2012C011C BE 2012C011 C BE2012C011 C BE 2012C011C BE 2012C011 I2 BE2012C011 I2 BE 2012C011I2
Authority
BE
Belgium
Prior art keywords
azalide
livestock
medicament
treating
manufacture
Prior art date
Application number
BE2012C011C
Other languages
German (de)
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806029.6A external-priority patent/GB9806029D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of BE2012C011I2 publication Critical patent/BE2012C011I2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to 8a-azalides which are used for the treatment and prevention of respiratory and enteral infections in animals, in particularly in cattle and pigs.The compounds are applied in a therapeutical and prophylactic effective quantity ensuring a level of antibacterial activity in the organism in the animals sufficient to inhibit the bacterial pathogenous agents of respiratory infections: Pasteurella haemolytica, P. multocida,Haemophilus somnus and Mycoplasma spp. in cattle, and Pasteurella multocida, Actinobacillus pheuropneumoniae and Mycoplasma spp. in pigs. 19 claims
BE2012C011C 1997-09-10 2012-03-21 The use of an 8a-azalide for the manufacture of a medicament for treating or preventing infections in livestock BE2012C011I2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5832997P 1997-09-10 1997-09-10
GBGB9806029.6A GB9806029D0 (en) 1998-03-20 1998-03-20 8a-Azalides as veterinary antimicrobial agents
EP98949319A EP1011664B1 (en) 1997-09-10 1998-09-04 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS

Publications (1)

Publication Number Publication Date
BE2012C011I2 true BE2012C011I2 (en) 2018-02-05

Family

ID=46203437

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2012C011C BE2012C011I2 (en) 1997-09-10 2012-03-21 The use of an 8a-azalide for the manufacture of a medicament for treating or preventing infections in livestock

Country Status (9)

Country Link
KR (1) KR100426510B1 (en)
AR (1) AR016920A1 (en)
BE (1) BE2012C011I2 (en)
BG (1) BG64765B1 (en)
CY (2) CY1112647T1 (en)
FR (1) FR12C0022I2 (en)
HR (1) HRP20000140A2 (en)
LU (1) LU91963I2 (en)
NO (1) NO312746B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions

Also Published As

Publication number Publication date
CY2012008I2 (en) 2016-04-13
HRP20000140A2 (en) 2000-12-31
NO312746B1 (en) 2002-07-01
CY2012008I1 (en) 2016-04-13
NO20001231L (en) 2000-05-08
KR100426510B1 (en) 2004-04-13
LU91963I2 (en) 2012-05-29
LU91963I9 (en) 2019-01-02
BG104235A (en) 2000-11-30
FR12C0022I2 (en) 2013-11-01
NO20001231D0 (en) 2000-03-09
CY1112647T1 (en) 2016-02-10
KR20010023822A (en) 2001-03-26
BG64765B1 (en) 2006-03-31
AR016920A1 (en) 2001-08-01
FR12C0022I1 (en) 2012-04-27

Similar Documents

Publication Publication Date Title
AU3699397A (en) Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases
ZA949344B (en) Treatment of poultry.
GR3034535T3 (en) Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer
EP0814825A4 (en) Method of treating or preventing non-viral microbial infection
PT806941E (en) LIPOSOMIC ANTI-BACTERIAL COMPOSITIONS OF LOW RIGIDITY
BR0013010A (en) Formulation of moxifloxacin sodium chloride
NZ297961A (en) Method of treating acid from accumulating in the GI tract
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
EP0589047A4 (en) Method of treating infectious disease, method of preventing putrefaction of cosmetic, and antibacterial/antifungal agent and cosmetic.
PL329376A1 (en) Carbapenemic compounds exhibiting antibacterial activity, compositions containing such compounds and medical treatment methods employing such compositions
BE2012C011I2 (en) The use of an 8a-azalide for the manufacture of a medicament for treating or preventing infections in livestock
WO1999012552A8 (en) 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
CA2301872A1 (en) 8a-azalides as veterinary antimicrobial agents
GB2377638B (en) Treatment of infection in animals
EP0286802A3 (en) Use of ofloxacin in treating or preventing locally periodontal disease
GB0106182D0 (en) Ingestible compositions comprising antibacterial agents
BR9800686A (en) Coccidicidal and bactericidal agent for birds and pigs.
EP0796105A4 (en) Pharmaceutical compositions for the treatment of autoimmune diseases comprising the b-oligomer of pertussis toxin or its subunits
ATE324892T1 (en) ANTIMUTAGEGENIC AGENT
AU2500788A (en) Veterinary treatment
Kitahara Methods of enhancing the treatment of infections- Secrets to the selection and use of antibiotics
WO1998014567A3 (en) Methods and compositions for inhibiting bacterial growth
EP0498243A3 (en) Fosfomycin cetyltrimethylammonium salt and composition containing it, for the topical treatment of vaginal and urethral infections
ZA9610381B (en) Oral veterinary composition containing a fluoroquinolone antibacterial agent possessing superior absorption properties and an extended duration of therapeutic antimicrobial blood levels and a method of treating a microbial infection in a ruminant
CO4810229A1 (en) ORAL VETERINARY COMPOSITION CONTAINING AN ANTIBACTERIAL AGENT OF FLUOROQUINOLONE WITH SUPERIOR PROPERTIES OF ABSORPTION AND EXTENDED DURATION OF ANTI-MICROBIAL THERAPEUTIC BLOOD LEVELS AND TREATMENT METHOD